Estrogen regulation of gene expression in osteoblasts and osteoclasts

Critical Reviews in Eukaryotic Gene Expression

Volumn 8, Issue 2, 1998, Pages 125-140

  Oursler, Merry Jo ^a  

^a UNIVERSITY OF MINNESOTA DULUTH   (United States)

Author keywords

Bone formation; Bone resorption; Osteoclastogenesis; Osteoporosis

Indexed keywords

CYTOKINE; ESTROGEN;

CELL PROLIFERATION; CYTOKINE PRODUCTION; ESTROGEN ACTIVITY; GENE EXPRESSION REGULATION; HORMONAL REGULATION; HUMAN; NONHUMAN; OSTEOBLAST; OSTEOCLAST; PRIORITY JOURNAL; REVIEW;

MAMMALIA;

EID: 0032471204     PISSN: 10454403     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevEukarGeneExpr.v8.i2.20     Document Type: Review

References (125)

1. Al-Humidan A, Ralston SH, Hughes DE, Chapman K, Aarden L, Russell RGG, Gowen M (1991): Interleukin-6 does not stimulate bone resorption in neonatal mouse calvariae. J Bone Miner Res 6:3-8.
2. Anderson F, Collin-Osdoby P, Sunyer T, Tothe L, Maloney W, Miller G, Osdoby P (1997): Isolation, culture, and characterization of authentic human bone-resorptive osteoclasts (Ocs). J Bone Miner Res 12(Suppl 1):S199.
3. Arnett TR, Linday R, Kilb JM, Moonga BS, Spowage M, Dempster DW (1996): Selective toxic effects of tamoxifen on osteoclasts: comparison with the effects of estrogen. J Endocrinol 149:503-508.
4. Bankson DD, Rifai N, Williams ME, Silverman LM, Gray TK (1989): Biochemical effects of 17β-estradiol on UMR 106 cells. Bone Miner 6:55-63.
5. Bell KL, Loveridge N, Lindsay PC, Lunt M, Garrahan N, Compston JE, Reeve J (1997): Cortical remodeling following suppression of endogenous estrogen with analogs of gonadotrophin releasing hormone. J Bone Miner Res 12:1231-1240.
6. Benz DJ, Haussler MR, Komm BS (1991): Estrogen binding and estrogenic responses in normal osteoblast-like cells. J Bone Miner Res 6:531-641.
7. Bodine PVN, Green J, Harris HA, Bhat RA, Stein GS, Lian JB, Komm BS (1997): Functional properties of a conditionally phenotypic, estrogen-responsive, human oseoblast cell line. J Cell Biochem 65:368-387.
8. Bodo M, Venti Donti G, Becchetti E, Pexxetti F, Palvdetti G, Donti E, Maurizi M (1991): Effects of steroid on human normal and otoscleroitic osteoblastic cells: influence on thymidine and leucine uptake and incorporation. Cell Molec Biol 37:597-606.
9. Boyce BF, Wright K, Reddy SV, Koop BA, Story B, Devlin R, Leach RJ, Roodman GD, Windle JJ (1995): Targeting simian virus 40 T antigen to the osteoclast in transgenic mice causes osteoclast tumors and transformation and apoptosis of osteoclasts. Endocrinology 136:5751-5759.
10. Brubaker KD, Gay CV (1994): Specific binding of estrogen to osteoclast surfaces. Biochem Biophys Res Commun 200:899-907.
11. Brubaker KD, Gay CV (1997): Evidence for plasma membrane estrogen receptors and rapid signalling events in osteoclasts. J Bone Miner Res 12:abstract 128.
12. Chaudhary LR, Spelsberg TC, Riggs BL (1992): Production of various cytokines by normal human osteoblast-like cells in response to interleukin-1β and tumor necrosis factor-α: lack of regulation by 17β-estradiol. Endocrinology 130:2528-2534.
13. Cissel DS, Murty M, Whipkey DL, Blaha JD, Graeber GM, Keeting PE (1996): Estrogen pretreatment increases arachidonic acid release by bradykinin stimulated normal human osteoblast-like cells. J Cell Biochem 60:260-270.
14. Cohen-Solal ME, Graulet AM, Denne MA, Gueris J, Baylink D, de Vernejoul MC (1993): Peripheral monocyte culture supernatants of menopausal women can induce bone resorption: involvement of cytokines. J Clin Endocrinol Metab 77:1648-1653.
15. Collier FM, Huang WH, Holloway WR, Hodge JM, Gillespie MT, Daniels LL, Zheng MH, Nicholson GC (1998): Osteoclasts from human giant cell tumors of bone lack estrogen receptors. Endocrinology 139:1258-1267.
16. Colston KW, King RJB, Hayward J, Fraser DI, Horton MA, Stevenson JC, Arnett TR (1989): Estrogen receptors and human bone cells: immunocytochemical studies. J Bone Miner Res 4:625-631.
17. Damoulis PD, Hauschka PV (1997): Nitric oxide acts in conjunction with proinflammatory cytokines to promote cell death in osteoblasts. J Bone Miner Res 12:412-422.
18. Denton R, Dupont S, Kim P, Garnier JM, Chambon P, Baron R (1997): Identification of a novel estrogen receptor beta and isoforms expressed in bone and ovary. J Bone Miner Res 12(Suppl 1):S111.
19. Ericksen EF, Colvard DS, Berg NJ, Graham ML, Mann KG, Spelsberg TC, Riggs BL (1980): Evidence of estrogen receptors in normal human osteoblast-like cells. Science 241:84-86.
20. Erlebacher A, Derynck R (1996): Increased expression of TGF-β2 in osteoblasts results in an osteoporosis-like phenotype. J Cell Biol 132:195-210.
21. Ernst M, Heath JK, Rodan GA (1989): Estradiol effects on proliferation, messenger ribonucleic acid for collagen and insulin-like growth factor-I and parathyroid hormone-stimulated adeylate cyclase activity in osteoblastic cells from calvariae and long bones. Endocrinology 125:825-833.
22. Ernst M, Rodan GA (1991): Estradiol regulation of insulin-like growth factor-I expression in osteoblastic cells: evidence for transcriptional control. Mol Endocrinol 5:1081-1089.
23. Fiorelli G, Gori F, Frediani U, Franceschelli F, Tanini A, TostiGuerra C, Benvenuti S, Gennari L, Becherini L, Brandi ML (1996): Membrane binding sites and nongenomic effects of estrogen in cultured human preosteoclastic cells. J Steroid Biochem Molec Biol 59:233-240.
24. Fukayama S, Tashjian AH (1989): Direct modulation by estradiol of the response of human bone cells (SaOS-2) to human parathyroid hormone (PTH) and PTH-related protein. Endocrinology 124:397-401.
25. Girasole G, Jilka RL, Passeri G, Boswell S, Boder G, Williams DC, Manolagas SC (1992): 17β-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteporotic effect of estrogens. J Clin Invest 89:883-891.
26. Girasole G, Passeri G, Jilka RL, Manolagas SC (1994): Interleukin-11: A new cytokine critical for osteoclast development. J Clin Invest 93:1516-1524.
27. Gray TK, Mohan S, Linkhart TA, Baylink DJ (1989): Estradiol stimulates in vitro the secretion of insulin-like growth factors by the clonal osteoblastic cell line UMN 106. Biochem Biophys Res Commun 158:407-412.
28. Greenfield EM, Shaw SM, Gornik SA, Banks MA (1995): Adenyl cyclase and interleukin 6 are downstream effectors of parathyroid hormone resulting in stimulation of bone resorption. J Clin Invest 96:1238-1244.
29. Hale AJ, Smith CA, Sutherland LC, Stoneman VEA, Longthorne VL, Culhane AC, Williams GT (1996): Apoptosis: molecular regulation of cell death. Eur J Biochem 236:1-26.
30. Hall TJ, Nyugen H, Schaueblin M, Fournier B (1995): The bone-specific estrogen centchroman inhibits osteoclastic bone resorption in vitro. Biochem Biophys Res Commun 216:662-668.
31. Hannun YA, Obeid LM (1995): Ceramide: an intracellular signal for apoptosis. Trends Biochem 20:73-77.
32. Herrmann JL, Bruckheimer E, McDonnell TJ (1996): Cell death signal transduction and Bc1-2 function. Biochem Soc Trans 24.
33. Hong MH, Williams H, Jin CH, Pike JW (1994): 17 β-estradiol suppresses mouse osteoelast differentiation and function in vitro via the estrogen receptor. J Bone Miner Res 9:S161.
34. Hoyland JA, Mee AP, Baird P, Braidman IP, Mawer EB, Freemont AJ (1997): Demonstration of estrogen receptor mRNA in bone using in situ reverse transcriptase polymerase chain reaction. Bone 20:87-92.
35. Hughes DE, Dai AH, Tiffee JC, Li HH, Mundy GR, Boyce BF (1996): Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta. Nature Medicien 2:1132-1136.
36. Hughes DE, Wright KR, Uy HL, Sasaki A, Yoneda Y, Roodman GD, Mundy GR, Boyce BF (1995): Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J Bone Miner Res 10:1478-1487.
37. Hughes DF, Wright KR, Mundy GR, Boyce BF (1994): TGFβ1 induces osteoelast apoptosis in vitro. J Bone Miner Res 9 (Suppl.):S138.
38. Ikegami A, Inoue S, Hosoi T, Kaneki M, Mizuno Y, Akedo Y, Ouchi Y, Orimo H (1994): Cell cycle-dependent expression of estrogen receptor and effect of estrogen on proliferation of synchronized human osteoblast-like osteosarcoma cells. Endocrinology 135:782-789.
39. Ikegami A, Inoue S, Hosoi T, Mizuno Y, Nakamura T, Ouchi Y, Orimo H (1993): Immunohistochemical detection and northern blot analysis of estrogen receptor in osteoblastic cells. J Bone Miner Res 8:1103-1109.
40. Ishibe M, Nojima T, Ishibashi T, Koda T, Kaneda K, Rosier RN, Puzas JE (1995): 17 beta estradiol increases the receptor number and modulates the action of 1,25-dihydroxyvitamin D-3 in human osteosarcoma-derived osteoblast-like cells. Calcif Tissue Int 57:430-435.
41. Jilka RL, Hangoc G, Girasole G, Passeri G, Williams DC, Abrams JS, Boyce B, Broxmeyer H, Manolagas SC (1992): Increased osteoelast development after estrogen loss: mediation by interleukin-6. Science 257:88-91.
42. Jones JI, Clemmons DR (1995): Insulin-like growth factors and their binding proteins: biological actions. Endocrine Rev 16:2-34.
43. Kameda T, Mano H, Yusas T, Mori Y, Miyazawa K, Shiokawa M, Nakamaru Y, Hiroi E, Huiri K, Kfameda A, Yang NN, Hakeda Y, Kumegawa M (1997): Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts. J Exp Med 186:489-495.
44. Kameda T, Miyazawa K, Mori Y, Yuasa T, Shiokawa M, Nakamaru Y, Mano H, Hakeda Y, Kameda A, Kumegawa M (1996): Vitamin K2 inhibits osteoclastic bone resorption by inducing osteoclast apoptosis. Biochem Biophys Res Commun 220:515-519.
45. Kassem M, Harris SA, Spelsberg TC, Riggs BL (1996a): Estrogen inhibits interleukin-6 production and gene expression in a human osteoblastic cell line with high levels of estrogen receptors. J Bone Miner Res 11:193-199.
46. Kassem M, Khosla S, Spelsberg TC, Riggs BL (1996b): Cytokine production in the bone marrow microenvironment: failure to demonstrate estrogen regulation in early postmenopausal women. J Clin Endocrinol Metab 81:513-518.
47. Kassem M, Okazaki R, DeLeon D, Harris SA, Robinson JA, Spelsberg TC, Conover CA, Riggs BL (1996c): Potential mechanism of estrogen-mediated decrease in bone formation: estrogen increases production of inhibitory insulin-like growth factor-binding protein-4. Proc Assoc Am Phys 108:155-164.
48. Keeting PE, Scott RE, Colvard DS, Han IK, Spelsberg TC, Riggs BL (1991): Lack of a direct effect of estrogen on proliferation and differentiation of normal human osteoblast-like cells. J. Bone Miner Res 6:297-304.
49. Kimble RB, Bain S, Pacifici R (1997): The functional block of TNF but not of IL-6 prevents bone loss in ovariectomized mice. J Bone Miner Res 12:935-941.
50. Kimble RB, Matayoshi AB, Vannice JL, Kung VT, Williams C, Pacifici R (1995): Simultaneous block of interleukin 1 and tumor necrosis factor is required to completely prevent bone loss in the early post-ovariectomy period. Endocrinology 136:3054-3061.
51. Kirkwood KL, Dziak R, Bradford PG (1996): Inositol trisphosphate receptor gene expression and hormonal regulation in osteoblast-like cell lines and primary osteoblastic cell cultures. J Bone Miner Res 11:1889-1896.
52. Kitazawa R, Kimble RB, Vannice JL, Kung VT, Pacifici R (1994): Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice. J Clin Invest 94:2397-2406.
53. Komm BS, Terpening CM, Benz DJ, Graeme KA, Gallegas A, Kore M, Greene GL, O'Mally BW, Haussler MR (1980): Estrogen binding receptor mRNA and biologic response in osteoblast-like osteosarcoma cells. Science 241:81-83.
54. Kremer M, Judd J, Rifkin B, Auszmann J, Oursler MJ (1995): Estrogen modulation of osteoclast lysosomal enzyme secretion. J Cell Biochem 57:271-279.
55. Kudo Y, Iwaashita M, Iguchi T, Takeda Y, Kizuka N, Takano K, Murake T (1997): Estrogen and parathyroid hormone regulate insulin-like growth factor binding protein-4 in SaOS-2 cells. Life Sci 61:165-170.
56. Kudo Y, Iwashita M, Itatsu S, Iguchi T, Takeda Y (1996): Regulation of insulin-like growth factor-binding protein-4 protease activity by estrogen and parathyroid hormone in SaOS-2 cells: implications for the pathogenesis of postmenopausal osteoporosis. J Endocrinology 150:223-229.
57. Kuiper GGJM, Enmark R, Pelto-Huikko M, Nilsson S, Gustafsson JA (1996): Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93:5925-5930.
58. Lajevnesse D (1994): Effect of 17 beta-estradiol on human osteosarcoma cell line MG-63. Bone Miner 24:1-16.
59. Lieberherr M, Grosse B, Kachkache M, Balsan S (1993): Cell signaling and estrogens in female rat osteoblasts: a possible involvement of unconventional nonnuclear receptors. J Bone Miner Res 8:1365-1376.
60. Lin SC, Yamate T, Taguchi Y, Borba VZC, Girasole G, OBrian CA, Bellido T, Abe E, Manolagas SC (1997): Regulation of the gp80 and gp130 subunits of the IL-6 receptor by sex steroids in the murine bone marrow. J Clin Invest 100:1980-1990.
61. Lutton JD, Moonga BS, Dempster DW (1996): Osteoclast demise in the rat: physiological versus degenerative cell death. Exp Physiol 81:251-260.
62. Majeska RJ, Ryaby JT, Einhorn TA (1994): Direct modulation of osteoblastic activity with estrogen. J Bone Jt Surg 76:713-721.
63. Mano H, Yuasa T, Kameda T, Miyanzawa K, Nakamaru Y, Sjoplawa M, Mori Y, Yamada T, Miyata K, Shindo H, Azuma H, Hakeda Y, Kumegawa M (1996): Mammalian mature osteoclasts as estrogen target cells. Biochem Biophys Res Commun 223:637-642.
64. Manolagas SC (1995): Role of cytokines in bone resorption. Bone 17:63S-67S.
65. Masuyama A, Ouchi Y, Sato F, Hosoi T, Nakamura T, Orimo H (1992): Characteristics of steroid hormone receptors in MC3T3-E1 osteoblastic cells and effect of steroid hormones on cell proliferation. Calcif Tissue Int 51:376-381.
66. Mathiev E, Merregaert J (1994): Characterization of the stromal osteogenic cell line MN7: mRNA steady-state level of selected osteogenic markers depends on cell density and is influenced by 17 beta-estradiol. J Bone Miner Res 9:183-192.
67. McCarthy TL, Ji CH, Shu H, Casinghino S, Crothers K, Rotwein P, Centrella M (1997): 17 beta-estradiol potently suppresses cAMP-induced insulin-like growth factor-I gene activation in primary rat osteoblast cultures. J Biol Chem 272:18132-18139.
68. Migleaccio S, Davis VL, Gibson MK, Grany TK, Korach KL (1992): Estrogens modulate the responsiveness of osteoblast-like cells (ROS 17/2.8) stably transfected with estrogen receptor. Endocrinology 130:2617-2624.
69. Migliaccio A, Pagano M, Auricchio F (1993): Immediate and transient stimulation of protein tyrosine phosphorylation by estradiol in MCF-7 cells. Oncogene 8:2183-2191.
70. Miyaura C, Kenichior K, Masuazawa T, Chaki O, Onoe Y, Aoyagi M, Sasaki T, Tamura T, Koishihara Y, Ohsugi Y, Suda T (1995): Endogenous bone-resorbing factors in estrogen deficiency: cooperative effects of IL-1 and IL-6. J Bone Miner Res 10:1365-1373.
71. Mizuno Y, Hosoi T, Ikegami A, Inoue S, Nakamura T, Ouchi Y, Orimo H (1992): Immunohistochemical identification of estrogen receptor in osteoblast-like cell lines and mouse osteoclast-like multinucleated cells. J Bone Miner Res 7:S269.
72. Morley P, Whitfield JF, Vanderhyden BC, Tsang BK, Schwartz J-L (1992): A new, nongenomic estrogen action: the rapid release of intracellular calcium. Endocrinology 131:1305-1312.
73. Most W, van Beek E, Ruwhof C, Berzooijen RV, Aderveen A, Kopf M, Papapoulos S, Lowik C (1994): Osteoclastic resorption in interleukin-6 deficient mice. J Bone Miner Res 9:abstract 48.
74. Mundy GR (1993): Role of cytokines in bone resorption. J Cell Biochem 53:296-300.
75. Okazaki R, Conover CA, Harris SA, Spelsberg TC, Riggs BL (1995): Normal human osteoblast-like cells consistently express genes for insulin-like growth factors I and II but transformed human osteoblast cell lines do not. J Bone Miner Res 10:788-795.
76. Onoe Y, Miyaura C, Ohta H, Nozawa S, Suda T (1997): Expression of estrogen receptor β in rat bone. Endocrinology 138:4509-4512.
77. Oursler M, Osdoby P, Pyfferoen J, Spelsberg TC (1991a): Avian osteoclasts as estrogen target cells. Proc Natl Acad Sci USA 88:6613-6617.
78. Oursler MJ, Cortese C, Keeting P, Anderson MA, Bonde S, Riggs BL, Spelsberg TC (1991b): Modulation of transforming growth factor-β production in normal human osteoblast-like cells by 17β-estradiol and parathyroid hormone. Endocrinology 129:3313-3320.
79. Oursler MJ, Kassem M, Riggs BL, Spelsberg TC (1996): Regulation of bone cell function by gonadal steroids. In Marcus, Feldman, Kelsey (eds): "Osteoporosis," Academic Press, 237-260.
80. Oursler MJ, Landers JP, Riggs BL, Spelsberg TC (1993a): Estrogen affects osteoblasts and osteoclasts. Ann Med 25:361-371.
81. Oursler MJ, Pederson L, Fitzpatrick L, Riggs BL, Spelsberg TC (1994): Human giant cell tumors of the bone (osteoclastomas) are estrogen target cells. Proc Natl Acad Sci USA 91:5227-5231.
82. Oursler MJ, Pederson L, Pyfferoen J, Osdoby P, Fitzpatrick L, Spelsberg TC (1993b): Estrogen modulation of avian osteoclast lysosomal gene expression. Endocrinology 132:1373-1380.
83. Pacifici R (1996): Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res 11:1043-1051.
84. Pacifici R, Brown C, Puscheck E, Friedrich E, Slatopolsky E, Maffio D, McCracken R, Avioli LV (1990a): Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc Natl Acad Sci USA 88:5134-5138.
85. Pacifici R, Brown C, Rifas, L, Avioli LV (1990b): TNFα and GM-CSF secretion from human blood monocytes: effect of menopause and estrogen replacement. J Bone Miner Res 5:abst 145.
86. Pacifici R, Rifas L, McCracken R, Vered I, Mcmurtry C, Avioli L, Peck WA (1989): Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release. Proc Natl Acad Sci USA 86:2398-2402.
87. Paech K, Webb JP, Kuiper GGJM, Nilsson S, Gustafsson J, Kushner PJ, Scanlan TS (1997): Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites. Science 277:1508-1510.
88. Pan LC, Ke HZ, Simmons HA, Crawford DT, Chidsey-Frink KL, McCurdy SP, Schafer JR, Kimbro KS, Taki M, Korach KS, Thompson DD (1997): Estrogen receptoralpha knockout (ERKO) mice lose trabecular and cortical bone following ovariectomy. J Bone Miner Res 12(Suppl 1):S134.
89. Parfitt, AM (1979): Quantum concept of bone remodeling and turnover: implications for the pathogenesis of osteoporosis. Calcif Tissue Int 28:1-5.
90. Passeri G, Girasole G, Manolagas SC, Jilka RL (1994): Endogenous production of tumor necrosis factor by primary cultures of murine calvarial cells: influence on IL-6 production and osteoclast development. Bone Miner 24:109-126.
91. Pederson L, Kremer M, Foged NT, Winding B, Ritchie C, Fitzpatrick LA, Oursler MJ (1997): Evidence of a correlation of estrogen receptor level and avian osteoclast estrogen responsiveness. J Bone Miner Res 12:742-752.
92. Pensler JM, Radosevich JA, Higbee R, Langman CB (1990): Osteoclasts isolated from membranous bone in children exhibit nuclear estrogen and progesterone receptors. J Bone Miner Res 5:797-802.
93. Poli V, Balena R, Fattori E, Markatos A, Yamamoto M, Tanaka H, Ciliberto G, Rodan GA, Costantini F (1994): Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J 13:1189-1196.
94. Ralston SH (1994): Analysis of gene expression in human bone biopsies by polymerase chain reaction: evidence for enhanced cytokine expression in postmenopausal osteoporosis. J Bone Miner Res 9:883-890.
95. Rao LG, Wylie, Sutherland MS, Murry JM (1990): 17 beta-estradiol and parathyroid hormone potentiate each other's stimulatory effect on alkaline phosphatase activity in SaOS-2 cells in a differentiation dependent manner. Endocrinology 134:614-620.
96. Rickard D, Russell G, Gowen M (1992): Estradiol inhibits the release of tumor necrosis factor but not interleukin 6 from adult human osteoblasts in vitro. Osteoporosis Int 2:94-102.
97. Rickard DJ, Gowen M, MacDonald BR (1993): Proliferative responses to estradiol, IL-1 alpha and TGF-β by cells expressing alkalime phosphatase in human osteoblast-like cell cultures. Calcif Tissue Int 52:227-233.
98. Rickard DJ, Hofbauer LC, Bonde SK, Gori F, Spelsberg TC, Riggs BL (1998): Bone morphogenic protein-6 production in human osteoblastic cell lines - Selective regulation by estrogen. J Clin Invest 101:413-422.
99. Robey PG, Young MF, Flanders KC, Roche NS, Kondaiah P, Reddi AH, Termine JD, Sporn MB, Roberts AB (1987): Osteoblasts synthesize and respond to transforming growth factor-type beta (TGF-β) in vitro. J Cell Biol 105:457-463.
100. Robinson JA, Harris SA, Riggs BL, Spelsberg TC (1997): Estrogen regulation of human osteoblastic cell proliferation and differentiation. Endocrinology 138:2919-2927.
101. Robinson JA, Riggs BL, Spelsberg TC, Oursler MJ (1996): Osteoclasts and TGF-β: Estrogen mediated, isoform specific regulation of production. Endocrinology 137:615-621.
102. Roodman GD (1993): Role of cytokines in the regulation of bone resorption. Calcif Tissue Int 53(Suppl 1):S94-S98.
103. Sarma U, Edwards M, Motoyoshi K, Flanagan AM (1998): Inhibition of bone resorption by 17 beta-estradiol in human bone marrow cultures. J Cell Physiol 175:99-108.
104. Scheven BA, Damen CA, Hamilton NJ, Vehaar HS, Duursma SA (1992): Stimulatory effects of estrogen and progesterone on proliferation and differentiation of normal human osteoblast-like cells in vitro. Biochem Biophys Res Commun 186:54-60.
105. Selander KS, Monkkonen J, Karhukorpi EK, Harkonen P, Hannuniemi R, Vaananen HK (1996): Characteristics of clodronate-induced apoptosis in osteoclasts and macrophages. Mol Pharmacol 50:1127-1138.
106. Slootweg MC, Swolin D, Netelenbos JC, Isaksson OGP, Ohlsson CJ (1997): Estrogen enhances growth hormone receptor expression and growth hormone action in rat osteosarcoma cells and human osteoblast-like cells. J Endocrinol 155:159-164.
107. Somjen D, Weisman Y, Kaye AM (1995): Pretreatment with 1,25(OH)(2) vitamin D or 24,25(OH)(2) vitamin D increases synergistically responsiveness to sex steroids in skeletal-derived cells. J Steroid Biochem Mol Biol 55:211-217.
108. 3 rapidly alters phospholipid metabolism in the nuclear envelope of osteoblasts. J Cell Biochem 58:15-21.
109. Subramaniam M, Harris SA, Oursler MJ, Rasmussen K, Riggs BL, Spelsberg TC (1995): Identification of a novel TGF-β regulated gene encoding a putative zinc finger protein in human osteoblasts. Nucl Acids Res 23:4907-4912.
110. Suda T, Nakamura I, Jimi E, Takahashi N (1997): Regulation of osteoclast function. J Bone Miner Res 12:869-879.
111. Suda T, Takahashi N, Maritn TJ (1992): Modulation of osteoclast differentiation. Endocrine Rev 13:66-80.
112. Sunyer T, Lewis J, Osdoby P (1997a): Estrogen decreases the steady state levels of the IL-1 signaling receptor (type I) while increasing those of the IL-1 decoy receptor (type II) mRNAs in human osteoclast-like cells. J Bone Miner Res 12:abstract 131.
113. +-inhibited bone resorption. Endocrinology 138:2148-2162.
114. Takada Y, Baylink DJ, Linkhart T, Edwall D, Kumegawa M, Mohan S (1994): Calcitropic hormones and growth factors regulate osteoclast survival in vitro. J Bone Miner Res 9 (Suppl.):S311.
115. Takahashi N, Akatsu T, Udagawa N, Sasaki T, Yamaguchi A, Moseley JM, Martin TJ, Suda T (1988): Osteoblastic cells are involved in osteoclast formation. Endocrinology 123:2600-2602.
116. Tamura T, Udagawa N, Takahashi N, Miyaura C, Tanaka S, Yamada Y, Koishihara Y, Ohsugi Y, Kumaki K, Taga T, Kishimoto T, Suda T (1993): Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. Proc Natl Acad Sci USA 90:11924-11928.
117. Tau, KR, Hefferan TE, Waters KM, Robinson JA, Subramaniam M, Riggs BL, Spelsberg TC (1998): Estrogen regulation of a transforming growth factor-beta inducible early gene that inhibits deoxyribonucleaic acid synthesis in human osteoblasts. Endocrinology 139:1346-1353.
118. Turner RT, Riggs BL, Spelsberg TC (1994): Skeletal effects of estrogen. Endocrine Rev 15:275-300.
119. Udagawa N, Takahashi N, Katagiri T, Tamura T, Wada S, Findlay DM, Martin TJ, Hirota H, Taga T, Kishimoto T, Suda T (1995): Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors. J Exp Med 182:1461-1468.
120. Vargas SJ, Naprta A, Lee S-K, Kalinowski J, Kawaguchi H, Pilbeam CC, Raisz LG, Lorenzo JA (1996): Lack of evidence for an increase in interleukin-6 expression in adult murine bone, bone marrow, and marrow stromal cell cultures after ovariectomy. J Bone Miner Res 11:1926-1934.
121. Watts CKW, Parker MG, King RJB (1989): Stable transaction of estrogen receptor gene into a human osteosarcoma cell line. J Steroid Biochem 34:483-490.
122. Wehling M (1997): Specific, nongenomic actions of steroid hormones. Ann Rev Phys 59:365-393.
123. +-ATPase and bone resorption by tamoxifen and calmodulin antagonists. J Biol Chem 271:12488-12497.
124. Yang NN, Bryant HU, Hardikar S, Sato M, Galvin RJS, Glasebrook AL, Termine JD (1996): Estrogen and raloxifen stimulate transforming growth factor-beta 3 gene expression in rat bone: a potential mechanism for estrogen- or raloxifene-mediated bone maintenance. Endocrinology 137:2075-2084.
125. Zang XY, Tan YB, Pang ZL, Zhang WZ, Zhao J (1994): Effects of parathyroid hormone and estradiol on proliferation and function of human osteoblasts from fetal long bone. An in vitro study. Chinese Med J 107:600-603.